share_log

'Theriva Biologics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/982,211 Titled "Alkaline Phosphatase Agents For Treatment Of Radiation Disorders"' - USPTO

Benzinga Real-time News ·  Jan 23, 2023 12:07
'Theriva Biologics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/982,211 Titled "Alkaline Phosphatase Agents For Treatment Of Radiation Disorders"' - USPTO
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment